Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
NASDAQ:ENTX
Price:
2.51 USD
7.26%
Market Closed
Updated:
May 15, 2024
Entera Bio Ltd
EPS (Diluted)
|
Entera Bio Ltd
EPS (Diluted) Peer Comparison
Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
EPS (Diluted)
$0
|
CAGR 3-Years
20%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
EPS (Diluted)
$0
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
EPS (Diluted)
$0
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
EPS (Diluted)
$0
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
EPS (Diluted)
-$3
|
CAGR 3-Years
16%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
EPS (Diluted)
₪0
|
CAGR 3-Years
0%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
7%
|
See Also
What is Entera Bio Ltd's EPS (Diluted)?
EPS (Diluted)
-0.3
USD
-0.3
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's EPS (Diluted) amounts to -0.3 USD.
What is Entera Bio Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
19%
19%
Over the last year, the EPS (Diluted) growth was 31%. The average annual EPS (Diluted) growth rates for Entera Bio Ltd have been 20% over the past three years , 19% over the past five years .
You don't have any saved screeners yet
